Drug Interactions and the Pharmacist: Focus on Everolimus

Twelve-Month Frequency of Drug-Metabolizing Enzyme and Transporter-Based Drug-Drug Interaction Potential in Patients Receiving Oral Enzyme-Targeted Kinase Inhibitor Antineoplastic Agents

(2013) Steven J. Bowlin et al.   MAYO CLINIC PROCEEDINGS

Research and innovation in the development of everolimus for oncology

(2011) David Lebwohl et al.   Expert Opinion on Drug Discovery

CYP3A5 Genotype Does Not Influence Everolimus In Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients

(2011) Nicolas Picard et al.   TRANSPLANTATION

“Overcoming breast cancer drug resistance with mTOR inhibitors”. Could it be a myth or a real possibility in the short-term future?

(2010) Nadia Margariti et al.   BREAST CANCER RESEARCH AND TREATMENT

Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis

(2010) Priscilla F. McAuliffe et al.   Clinical Breast Cancer

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs

(2010) Jia-Jia Huang et al.   INVESTIGATIONAL NEW DRUGS

CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype–phenotype association study design in translational pharmacogenetics

(2010) Yutaro Suzuki et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Drug interactions in oncology: how common are they?

(2009) R. P. Riechelmann et al.   ANNALS OF ONCOLOGY

Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents

(2009) Terence O’Reilly et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Satraplatin, an Oral Platinum, Administered on a Five-day Every-Five-Week Schedule: a Pharmacokinetic and Food Effect Study

(2009) A. D. Ricart et al.   CLINICAL CANCER RESEARCH

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

(2008) Jingxiang Huang et al.   BIOCHEMICAL JOURNAL

Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo

(2008) Y. H. Ju et al.   CARCINOGENESIS

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

(2008) E. R. Gardner et al.   CLINICAL CANCER RESEARCH

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors

(2008) Anne O'Donnell et al.   JOURNAL OF CLINICAL ONCOLOGY

Review Article: Cytochrome P450 enzyme, and transport protein mediated herb–drug interactions in renal transplant patients: Grapefruit juice, St John's Wort – and beyond! (Review Article)

(2008) RAINER NOWACK   NEPHROLOGY

Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation

(2008) Marie H Hanigan et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE